Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (1-10 of 230) with videos related to

Pageof 23
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|September 29, 2007
Is metabolic syndrome the main threat to human health in the twenty-first century?Marja-Riitta Taskinen
Atherosclerosis. Supplements|June 5, 2002
Diabetic dyslipidemiaMarja-Riitta Taskinen
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 31, 2006
Should we dismiss fibrates for the treatment of diabetic dyslipidaemia?Marja-Riitta Taskinen
Current Diabetes Reports|April 12, 2007
The role of PPAR-alpha agonists in the prevention of CVD in diabetesMarja-Riitta Taskinen
Diabetes Research and Clinical Practice|July 26, 2003
LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit?Marja Riitta Taskinen
Arteriosclerosis, Thrombosis, and Vascular Biology|February 21, 2009
ADAGIO-Lipids gives promises but faces the setbacksMarja-Riitta Taskinen
Atherosclerosis. Supplements|July 24, 2012
Statins are diabetogenic--myth or reality?Naveed Sattar, Marja-Riitta Taskinen
Current Atherosclerosis Reports|September 11, 2016
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?Marja-Riitta Taskinen, Jan Borén
Atherosclerosis|February 24, 2015
New insights into the pathophysiology of dyslipidemia in type 2 diabetesMarja-Riitta Taskinen, Jan Borén
Duodecim; Laaketieteellinen Aikakauskirja|October 3, 2012
[New European clinical guidelines on dyslipidemias]Niina Matikainen, Marja-Riitta Taskinen
Pageof 23

Showing results (1-10 of 230) with videos related to

Sort By:
Pageof 23
Arteriosclerosis, Thrombosis, and Vascular Biology|September 29, 2007
Is metabolic syndrome the main threat to human health in the twenty-first century?Marja-Riitta Taskinen
Atherosclerosis. Supplements|June 5, 2002
Diabetic dyslipidemiaMarja-Riitta Taskinen
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 31, 2006
Should we dismiss fibrates for the treatment of diabetic dyslipidaemia?Marja-Riitta Taskinen
Current Diabetes Reports|April 12, 2007
The role of PPAR-alpha agonists in the prevention of CVD in diabetesMarja-Riitta Taskinen
Diabetes Research and Clinical Practice|July 26, 2003
LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit?Marja Riitta Taskinen
Arteriosclerosis, Thrombosis, and Vascular Biology|February 21, 2009
ADAGIO-Lipids gives promises but faces the setbacksMarja-Riitta Taskinen
Atherosclerosis. Supplements|July 24, 2012
Statins are diabetogenic--myth or reality?Naveed Sattar, Marja-Riitta Taskinen
Current Atherosclerosis Reports|September 11, 2016
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?Marja-Riitta Taskinen, Jan Borén
Atherosclerosis|February 24, 2015
New insights into the pathophysiology of dyslipidemia in type 2 diabetesMarja-Riitta Taskinen, Jan Borén
Duodecim; Laaketieteellinen Aikakauskirja|October 3, 2012
[New European clinical guidelines on dyslipidemias]Niina Matikainen, Marja-Riitta Taskinen
Pageof 23